News
News
- Basilea provides corporate update
05/28/2020 / 07:15 - GlobeNewswire - TCR² Therapeutics Hires Key Business Development and Regulatory Affairs Cell Therapy Experts to Support Strategic Objectives
05/27/2020 / 14:00 - GlobeNewswire - Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program
05/26/2020 / 20:11 - GlobeNewswire - CRISPR Therapeutics to Participate in Upcoming Investor Conferences
05/26/2020 / 14:30 - GlobeNewswire - Roche buys US DNA sequencing startup
05/22/2020 / 09:10 - TeleTrader - Seelos Therapeutics Announces Appointment of Judith Dunn to the Board of Directors
05/15/2020 / 16:30 - GlobeNewswire - CRISPR Therapeutics Announces Presentations at the American Association for Cancer Research 2020 Annual Meeting
05/15/2020 / 14:30 - GlobeNewswire - New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European Hematology Association (EHA) Congress
05/14/2020 / 15:02 - GlobeNewswire - TRACON Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update
05/13/2020 / 22:04 - GlobeNewswire - Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus
05/13/2020 / 13:00 - GlobeNewswire
Real-time